HSV-2-delta-gD vaccines and methods for their production and use
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
Nov 26, 2024
Grant Date -
Sep 21, 2023
app pub date -
Nov 29, 2022
filing date -
Nov 29, 2022
priority date (Note) -
In Force
status (Latency Note)
Importance
Calculated Rating
|
US Family Size
|
Non-US Coverage
|
Abstract
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, compositions and vaccines comprising such, and methods of use thereof are each provided.
First Claim
Other Claims data not available
Family
| Country | kind | publication No. | Filing Date | Type | Sub-Type |
|---|
International Classification(s)
- 2022 Application Filing Year
- A61K Class
- 20288 Applications Filed
- 3818 Patents Issued To-Date
- 18.82 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 1 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | May 26, 2028 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | May 26, 2032 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | May 26, 2036 |